{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:56:24Z","timestamp":1791309384697,"version":"4.3.1"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32571083"],"award-info":[{"award-number":["32571083"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wenzhou Major Scientific and Technological Innovation Project","award":["ZY2022015"],"award-info":[{"award-number":["ZY2022015"]}]},{"name":"Wenzhou Municipal Science and Technology Bureau Program","award":["Y2023075"],"award-info":[{"award-number":["Y2023075"]}],"id":[{"id":"https:\/\/ror.org\/02fr0s482","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LQN26H190002"],"award-info":[{"award-number":["LQN26H190002"]}],"id":[{"id":"https:\/\/ror.org\/04aqat463","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>\n                    Human cytomegalovirus (HCMV) is a major pathogen affecting immunocompromised individuals. Current antiviral drugs target the mid-to-late stages of viral replication but are limited by toxicity and drug resistance. The IE1 protein serves as a key early regulator of HCMV replication; however, it has long been considered undruggable due to the lack of conventional drug-binding sites. In this study, by integrating molecular docking-based virtual screening with\n                    <jats:italic>in-vitro<\/jats:italic>\n                    surface plasmon resonance (SPR) validation, we discovered for the first time that the HIV protease inhibitor ritonavir may bind to the IE1 protein. Further experiments demonstrated that ritonavir significantly reduces IE1 protein levels in a time- and dose-dependent manner without affecting its mRNA expression. Mechanistic investigations revealed that ritonavir promotes selective degradation of IE1 through activation of the ubiquitin-proteasome pathway. Functional assays confirmed that ritonavir effectively inhibits HCMV replication, markedly reducing viral DNA loads and the production of infectious viral particles. Notably, ritonavir exhibited synergistic antiviral effects when combined with the first-line drug ganciclovir (GCV). In summary, this study successfully repurposes the approved drug ritonavir as a regulator of IE1 protein expression, demonstrating not only its anti-HCMV activity and synergistic effects with GCV but also providing a new therapeutic strategy for HCMV infection.\n                  <\/jats:p>","DOI":"10.1371\/journal.pcbi.1014867","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:47:26Z","timestamp":1791308846000},"page":"e1014867","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Repurposing ritonavir to induce proteasomal degradation of IE1 for inhibition of human cytomegalovirus replication"],"prefix":"10.1371","volume":"22","author":[{"given":"Wanfeng","family":"Liu","sequence":"first","affiliation":[{"name":"Wenzhou Medical University","place":["Wenzhou, China"],"department":["Wenzhou Collaborative Innovation Center of Gastrointestinal Cancer in Basic Research and Precision Medicine, Wenzhou Key Laboratory of Cancer-related Pathogens and Immunity, Department of Microbiology and Immunology, School of Basic Medical Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Shi","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University","place":["Wenzhou, China"],"department":["Wenzhou Collaborative Innovation Center of Gastrointestinal Cancer in Basic Research and Precision Medicine, Wenzhou Key Laboratory of Cancer-related Pathogens and Immunity, Department of Microbiology and Immunology, School of Basic Medical Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Guo","sequence":"additional","affiliation":[{"name":"Northwest A&F University","place":["Xianyang, Shaanxi, China"],"department":["College of Information Engineering"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyu","family":"Lou","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University","place":["Wenzhou, China"],"department":["Wenzhou Collaborative Innovation Center of Gastrointestinal Cancer in Basic Research and Precision Medicine, Wenzhou Key Laboratory of Cancer-related Pathogens and Immunity, Department of Microbiology and Immunology, School of Basic Medical Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangyi","family":"Xie","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University","place":["Wenzhou, China"],"department":["Wenzhou Collaborative Innovation Center of Gastrointestinal Cancer in Basic Research and Precision Medicine, Wenzhou Key Laboratory of Cancer-related Pathogens and Immunity, Department of Microbiology and Immunology, School of Basic Medical Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitian","family":"Shen","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University","place":["Wenzhou, China"],"department":["Wenzhou Collaborative Innovation Center of Gastrointestinal Cancer in Basic Research and Precision Medicine, Wenzhou Key Laboratory of Cancer-related Pathogens and Immunity, Department of Microbiology and Immunology, School of Basic Medical Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Yuying Children\u2019s Hospital of Wenzhou Medical University","place":["Wenzhou, China"],"department":["The Second Affiliated Hospital"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunzhong","family":"Mao","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University","place":["Wenzhou, China"],"department":["Wenzhou Collaborative Innovation Center of Gastrointestinal Cancer in Basic Research and Precision Medicine, Wenzhou Key Laboratory of Cancer-related Pathogens and Immunity, Department of Microbiology and Immunology, School of Basic Medical Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Xue","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University","place":["Wenzhou, China"],"department":["Wenzhou Collaborative Innovation Center of Gastrointestinal Cancer in Basic Research and Precision Medicine, Wenzhou Key Laboratory of Cancer-related Pathogens and Immunity, Department of Microbiology and Immunology, School of Basic Medical Sciences"]},{"name":"The First Affiliated Hospital of Wenzhou Medical University","place":["Wenzhou, Zhejiang, China"],"department":["Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9622-9726","authenticated-orcid":true,"given":"Shiyu","family":"Feng","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University","place":["Wenzhou, China"],"department":["Wenzhou Collaborative Innovation Center of Gastrointestinal Cancer in Basic Research and Precision Medicine, Wenzhou Key Laboratory of Cancer-related Pathogens and Immunity, Department of Microbiology and Immunology, School of Basic Medical Sciences"]},{"name":"The First Affiliated Hospital of Wenzhou Medical University","place":["Wenzhou, Zhejiang, China"],"department":["Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"issue":"1","key":"pcbi.1014867.ref001","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1186\/s12889-022-13971-7","article-title":"A systematic literature review of the global seroprevalence of cytomegalovirus: Possible implications for treatment, screening, and vaccine development","volume":"22","author":"K Fowler","year":"2022","journal-title":"BMC Public Health"},{"issue":"1","key":"pcbi.1014867.ref002","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1186\/s12879-019-4643-6","article-title":"Cytomegalovirus infection in HIV-infected patients in the era of combination antiretroviral therapy","volume":"19","author":"R Perello","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"16","key":"pcbi.1014867.ref003","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.3390\/ijms20163865","article-title":"Cytomegalovirus (CMV) pneumonitis: Cell tropism, inflammation, and immunity","volume":"20","author":"L Fonseca Brito","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"pcbi.1014867.ref004","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3390\/pathogens13050417","article-title":"Human cytomegalovirus infection and neurocognitive and neuropsychiatric health","volume":"13","author":"SD Gale","year":"2024","journal-title":"Pathogens"},{"issue":"1","key":"pcbi.1014867.ref005","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.00062-12","article-title":"The \u201csilent\u201d global burden of congenital cytomegalovirus","volume":"26","author":"S Manicklal","year":"2013","journal-title":"Clin Microbiol Rev"},{"issue":"7","key":"pcbi.1014867.ref006","doi-asserted-by":"crossref","first-page":"515","DOI":"10.6061\/clinics\/2015(07)09","article-title":"Cytomegalovirus infection in transplant recipients","volume":"70","author":"LS Azevedo","year":"2015","journal-title":"Clinics (Sao Paulo)"},{"key":"pcbi.1014867.ref007","doi-asserted-by":"crossref","first-page":"771978","DOI":"10.3389\/fmicb.2022.771978","article-title":"Analysis of novel drug-resistant human cytomegalovirus DNA polymerase mutations reveals the role of a DNA-binding loop in phosphonoformic acid resistance","volume":"13","author":"KR Park","year":"2022","journal-title":"Front Microbiol"},{"issue":"19","key":"pcbi.1014867.ref008","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1309533","article-title":"Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation","volume":"370","author":"RF Chemaly","year":"2014","journal-title":"N Engl J Med"},{"issue":"7","key":"pcbi.1014867.ref009","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/TP.0000000000005374","article-title":"The fourth international consensus guidelines on the management of cytomegalovirus in solid organ transplantation","volume":"109","author":"CN Kotton","year":"2025","journal-title":"Transplantation"},{"issue":"5","key":"pcbi.1014867.ref010","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1684\/vir.2024.1063","article-title":"Challenges and advances in the management of HCMV infections","volume":"28","author":"C Gourin","year":"2024","journal-title":"Virologie (Montrouge)"},{"issue":"12","key":"pcbi.1014867.ref011","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1080\/14656566.2019.1637418","article-title":"An overview of letermovir: A cytomegalovirus prophylactic option","volume":"20","author":"G Gerna","year":"2019","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"pcbi.1014867.ref012","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1128\/jvi.69.4.2194-2207.1995","article-title":"Human cytomegalovirus (HCMV) immediate-early enhancer\/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection","volume":"69","author":"M Koedood","year":"1995","journal-title":"J Virol"},{"issue":"3","key":"pcbi.1014867.ref013","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3390\/v1030760","article-title":"The human cytomegalovirus major immediate-early proteins as antagonists of intrinsic and innate antiviral host responses","volume":"1","author":"C Paulus","year":"2009","journal-title":"Viruses"},{"issue":"6","key":"pcbi.1014867.ref014","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1128\/jvi.71.6.4599-4613.1997","article-title":"The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells","volume":"71","author":"JH Ahn","year":"1997","journal-title":"J Virol"},{"issue":"3","key":"pcbi.1014867.ref015","article-title":"Human cytomegalovirus IE2 both activates and represses initiation and modulates elongation in a context-dependent manner","volume":"13","author":"CB Ball","year":"2022","journal-title":"mBio"},{"issue":"4","key":"pcbi.1014867.ref016","article-title":"Human cytomegalovirus IE2 drives transcription initiation from a select subset of late infection viral promoters by host RNA polymerase II","volume":"16","author":"M Li","year":"2020","journal-title":"PLoS Pathog"},{"issue":"12","key":"pcbi.1014867.ref017","doi-asserted-by":"crossref","first-page":"10458","DOI":"10.1128\/JVI.73.12.10458-10471.1999","article-title":"The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10)","volume":"73","author":"JH Ahn","year":"1999","journal-title":"J Virol"},{"issue":"9","key":"pcbi.1014867.ref018","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3390\/v10090447","article-title":"Who\u2019s driving? Human cytomegalovirus, interferon, and NF\u03baB signaling","volume":"10","author":"CM Goodwin","year":"2018","journal-title":"Viruses"},{"issue":"7","key":"pcbi.1014867.ref019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005748","article-title":"Human cytomegalovirus immediate-early 1 protein rewires upstream STAT3 to downstream STAT1 signaling switching an IL6-type to an IFN\u03b3-like response","volume":"12","author":"T Harwardt","year":"2016","journal-title":"PLoS Pathog"},{"issue":"1","key":"pcbi.1014867.ref020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/v6010089","article-title":"Identification of cellular proteins that interact with human cytomegalovirus immediate-early protein 1 by protein array assay","volume":"6","author":"FP Mart\u00ednez","year":"2013","journal-title":"Viruses"},{"issue":"17","key":"pcbi.1014867.ref021","doi-asserted-by":"crossref","first-page":"8028","DOI":"10.1128\/JVI.74.17.8028-8037.2000","article-title":"Role of human cytomegalovirus immediate-early proteins in cell growth control","volume":"74","author":"JP Castillo","year":"2000","journal-title":"J Virol"},{"key":"pcbi.1014867.ref022","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1099\/0022-1317-81-6-1553","article-title":"Human cytomegalovirus mediates cell cycle progression through G(1) into early S phase in terminally differentiated cells","volume":"81","author":"J Sinclair","year":"2000","journal-title":"J Gen Virol"},{"issue":"1","key":"pcbi.1014867.ref023","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/v12010110","article-title":"Bright and early: Inhibiting human cytomegalovirus by targeting major immediate-early gene expression or protein function","volume":"12","author":"CS Adamson","year":"2020","journal-title":"Viruses"},{"issue":"10","key":"pcbi.1014867.ref024","doi-asserted-by":"crossref","first-page":"5660","DOI":"10.1128\/JVI.06338-11","article-title":"RNA interference-mediated targeting of human cytomegalovirus immediate-early or early gene products inhibits viral replication with differential effects on cellular functions","volume":"86","author":"E Xiaofei","year":"2012","journal-title":"J Virol"},{"issue":"8","key":"pcbi.1014867.ref025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009863","article-title":"Cytomegalovirus immediate-early 1 proteins form a structurally distinct protein class with adaptations determining cross-species barriers","volume":"17","author":"J Schweininger","year":"2021","journal-title":"PLoS Pathog"},{"key":"pcbi.1014867.ref026","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkac1077","article-title":"RCSB Protein Data Bank (RCSB.org): Delivery of experimentally-determined PDB structures alongside one million computed structure models of proteins from artificial intelligence\/machine learning","volume":"51","author":"SK Burley","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pcbi.1014867.ref027","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/ci049714+","article-title":"ZINC--a free database of commercially available compounds for virtual screening","volume":"45","author":"JJ Irwin","year":"2005","journal-title":"J Chem Inf Model"},{"issue":"2","key":"pcbi.1014867.ref028","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.tips.2014.12.001","article-title":"Beware of docking!","volume":"36","author":"Y-C Chen","year":"2015","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"pcbi.1014867.ref029","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"LJ Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"pcbi.1014867.ref030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/B978-012465330-6\/50003-8","article-title":"Virus isolation and quantitation.","author":"JC Hierholzer","year":"1996","journal-title":"Virology methods manual. Elsevier"},{"issue":"23","key":"pcbi.1014867.ref031","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1056\/NEJM199512073332204","article-title":"A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection","volume":"333","author":"M Markowitz","year":"1995","journal-title":"N Engl J Med"},{"key":"pcbi.1014867.ref032","doi-asserted-by":"crossref","first-page":"114367","DOI":"10.1016\/j.biopha.2023.114367","article-title":"Paxlovid (Nirmatrelvir\/Ritonavir): A new approach to Covid-19 therapy?","volume":"162","author":"SMR Hashemian","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"pcbi.1014867.ref033","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1586\/17474124.2015.1032938","article-title":"Ritonavir-boosted protease inhibitor based therapy: A new strategy in chronic hepatitis C therapy","volume":"9","author":"SW Brayer","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"3","key":"pcbi.1014867.ref034","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10557-020-07070-1","article-title":"Lopinavir-ritonavir in SARS-CoV-2 infection and drug-drug interactions with cardioactive medications","volume":"35","author":"S Agarwal","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"key":"pcbi.1014867.ref035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-3-319-53168-7_4","article-title":"The human CMV IE1 protein: An offender of PML nuclear bodies","volume":"223","author":"M Scherer","year":"2017","journal-title":"Adv Anat Embryol Cell Biol"},{"issue":"4","key":"pcbi.1014867.ref036","article-title":"The human cytomegalovirus IE1 protein antagonizes PML nuclear body-mediated intrinsic immunity via the inhibition of PML de novo SUMOylation","volume":"91","author":"E-M Schilling","year":"2017","journal-title":"J Virol"},{"issue":"21","key":"pcbi.1014867.ref037","doi-asserted-by":"crossref","first-page":"10444","DOI":"10.1128\/JVI.00833-08","article-title":"Binding STAT2 by the acidic domain of human cytomegalovirus IE1 promotes viral growth and is negatively regulated by SUMO","volume":"82","author":"YH Huh","year":"2008","journal-title":"J Virol"},{"issue":"24","key":"pcbi.1014867.ref038","doi-asserted-by":"crossref","first-page":"12854","DOI":"10.1128\/JVI.01164-09","article-title":"Physical requirements and functional consequences of complex formation between the cytomegalovirus IE1 protein and human STAT2","volume":"83","author":"S Krauss","year":"2009","journal-title":"J Virol"},{"issue":"11","key":"pcbi.1014867.ref039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004512","article-title":"Crystal structure of cytomegalovirus IE1 protein reveals targeting of TRIM family member PML via coiled-coil interactions","volume":"10","author":"M Scherer","year":"2014","journal-title":"PLoS Pathog"},{"issue":"1","key":"pcbi.1014867.ref040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13045-020-00885-3","article-title":"Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy","volume":"13","author":"X Li","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"6","key":"pcbi.1014867.ref041","doi-asserted-by":"crossref","first-page":"104376","DOI":"10.1016\/j.drudis.2025.104376","article-title":"PROTAC 2.0: Expanding the frontiers of targeted protein degradation","volume":"30","author":"M Cornu","year":"2025","journal-title":"Drug Discov Today"},{"key":"pcbi.1014867.ref042","doi-asserted-by":"crossref","first-page":"105480","DOI":"10.1016\/j.antiviral.2022.105480","article-title":"Targeted protein degradation as an antiviral approach","volume":"210","author":"A Chakravarty","year":"2023","journal-title":"Antiviral Res"},{"key":"pcbi.1014867.ref043","doi-asserted-by":"crossref","first-page":"118208","DOI":"10.1016\/j.ejmech.2025.118208","article-title":"Antiviral strategies based on targeted protein degradation: An overview of the literature and future outlook","volume":"301","author":"F Zhou","year":"2026","journal-title":"Eur J Med Chem"},{"issue":"1","key":"pcbi.1014867.ref044","doi-asserted-by":"crossref","first-page":"103847","DOI":"10.1016\/j.drudis.2023.103847","article-title":"Targeted degrader technologies as prospective SARS-CoV-2 therapies","volume":"29","author":"R Khurshid","year":"2024","journal-title":"Drug Discov Today"},{"issue":"8","key":"pcbi.1014867.ref045","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nm0898-953","article-title":"Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1","volume":"4","author":"KV Komanduri","year":"1998","journal-title":"Nat Med"},{"issue":"7","key":"pcbi.1014867.ref046","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.ophtha.2015.02.033","article-title":"Long-term outcomes of cytomegalovirus retinitis in the era of modern antiretroviral therapy: Results from a United States cohort","volume":"122","author":"DA Jabs","year":"2015","journal-title":"Ophthalmology"},{"issue":"9","key":"pcbi.1014867.ref047","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1021\/acs.jcim.6c00311","article-title":"DRHIN: An integrated and interactive web server for drug repositioning","volume":"66","author":"B Zhao","year":"2026","journal-title":"J Chem Inf Model"},{"issue":"1","key":"pcbi.1014867.ref048","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41598-017-01077-9","article-title":"Atom size electron vortex beams with selectable orbital angular momentum","volume":"7","author":"D Pohl","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"pcbi.1014867.ref049","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41592-024-02516-y","article-title":"SurfDock is a surface-informed diffusion generative model for reliable and accurate protein-ligand complex prediction","volume":"22","author":"D Cao","year":"2025","journal-title":"Nat Methods"},{"key":"pcbi.1014867.ref050","article-title":"LiTENexus: An end-to-end virtual drug discovery system based on quantum chemical grounding","volume":"2026","author":"Q Su","year":"2026","journal-title":"ChemRxiv"}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1014867","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:47:34Z","timestamp":1791308854000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1014867"}},"subtitle":[],"editor":[{"given":"Dominik","family":"Wodarz","sequence":"first","affiliation":[{"name":"University of California San Diego Division of Biological Sciences","place":["UNITED STATES OF AMERICA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1014867","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]}}}